Synthesis and anticancer activity of benzyloxybenzaldehyde derivatives against HL-60 cells

[Display omitted] A series of benzyloxybenzaldehyde derivatives were prepared and tested against the HL-60 cell line for anticancer activity. Preliminary structure–activity relationships were established. It was discovered that 2-(benzyloxy)benzaldehyde ( 17), 2-(benzyloxy)-4-methoxybenzaldehyde ( 2...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 13; no. 5; pp. 1537 - 1544
Main Authors Lin, Chin-Fen, Yang, Jai-Sing, Chang, Chiung-Yun, Kuo, Sheng-Chu, Lee, Miau-Rong, Huang, Li-Jiau
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.03.2005
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] A series of benzyloxybenzaldehyde derivatives were prepared and tested against the HL-60 cell line for anticancer activity. Preliminary structure–activity relationships were established. It was discovered that 2-(benzyloxy)benzaldehyde ( 17), 2-(benzyloxy)-4-methoxybenzaldehyde ( 26), 2-(benzyloxy)-5-methoxybenzaldehyde ( 27), 2-(benzyloxy)-5-chlorobenzaldehyde ( 28), 2-[(3-methoxybenzyl)oxy]benzaldehyde ( 29), 2-[(2-chlorobenzyl)oxy]benzaldehyde ( 30), and 2-[(4-chlorobenzyl)oxy]benzaldehyde ( 31) exhibited significant activity at 1–10 μM. Among them, compound 29 was the most potent one. The morphological assessment and DNA fragmentation analysis indicated that these compounds arrested cell cycle progression at G2/M phase and induced cell apoptosis. They resulted in the loss of mitochondrial membrane potential after 12 h of treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2004.12.026